• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病的多种临床特征与突变 HTT 基因 CAG 重复长度和神经退行性变相关。

Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.

机构信息

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, 9500 Gilman Drive, MC0719, La Jolla, San Diego, CA, 92093-0719, USA.

Department of Neurosciences, University of California, 9500 Gilman Drive, MC0719, La Jolla, San Diego, CA, 92093-0719, USA.

出版信息

J Neurol. 2019 Mar;266(3):551-564. doi: 10.1007/s00415-018-8940-6. Epub 2018 Jun 28.

DOI:10.1007/s00415-018-8940-6
PMID:29956026
Abstract

Huntington's disease (HD) is a fatal neurodegenerative disease caused by mutant HTT gene expansions of CAG triplet repeat numbers that are inherited in an autosomal dominant manner. HD patients display multiple clinical features that are correlated with HTT CAG repeat numbers that include age of disease onset, motor dysfunction, cognitive deficits, compromised daily living capacity, and brain neurodegeneration. It is important to understand the significant relationships of the multiple HD clinical deficits correlated with the number of mutant HTT CAG expansions that are the genetic basis for HD disabilities. Therefore, this review highlights the significant correlations of the HD clinical features of age of onset, motor and cognitive disabilities, decline in living capabilities, weight loss, risk of death, and brain neurodegeneration with respect to their associations with CAG repeat lengths of the HTT gene. Quantitative HTT gene expression patterns analyzed in normal adult human brain regions demonstrated its distribution in areas known to undergo neurodegeneration in HD, as well as in other brain regions. Future investigation of the relationships of the spectrum of clinical HD features with mutant HTT molecular mechanisms will be important to gain understanding of how mutant CAG expansions of the HTT gene result in the devastating disabilities of HD patients.

摘要

亨廷顿病 (HD) 是一种致命的神经退行性疾病,由 HTT 基因突变引起,该基因中的 CAG 三核苷酸重复数呈常染色体显性遗传。HD 患者表现出多种与 HTT CAG 重复数相关的临床特征,包括发病年龄、运动功能障碍、认知缺陷、日常生活能力受损以及大脑神经退行性变。了解与突变 HTT CAG 扩展数相关的多个 HD 临床缺陷的显著相关性非常重要,这些相关性是 HD 残疾的遗传基础。因此,本综述重点介绍了 HD 临床特征与 HTT 基因突变 CAG 重复长度的相关性,这些特征包括发病年龄、运动和认知障碍、生活能力下降、体重减轻、死亡风险以及大脑神经退行性变。对正常成年人大脑区域中定量 HTT 基因表达模式的分析表明,它分布在已知在 HD 中发生神经退行性变的区域以及其他大脑区域。未来对 HD 临床特征与突变 HTT 分子机制之间关系的研究将有助于了解 HTT 基因突变 CAG 重复扩展如何导致 HD 患者的毁灭性残疾。

相似文献

1
Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.亨廷顿病的多种临床特征与突变 HTT 基因 CAG 重复长度和神经退行性变相关。
J Neurol. 2019 Mar;266(3):551-564. doi: 10.1007/s00415-018-8940-6. Epub 2018 Jun 28.
2
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.具有225个CAG重复序列的新型亨廷顿舞蹈病BAC小鼠模型表现出早期广泛且稳定的退化表型。
J Huntingtons Dis. 2015;4(1):17-36.
3
Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.亨廷顿舞蹈病中突变型HTT CAG重复序列不稳定性的亲本来源差异
Eur J Med Genet. 2011 Jul-Aug;54(4):e413-8. doi: 10.1016/j.ejmg.2011.04.002. Epub 2011 Apr 23.
4
N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease.N-末端突变亨廷顿蛋白沉积与 CAG 重复长度和症状发作相关,但与亨廷顿病的神经元丢失无关。
Neurobiol Dis. 2022 Nov;174:105884. doi: 10.1016/j.nbd.2022.105884. Epub 2022 Oct 8.
5
Clinical and genetic characteristics in patients with Huntington's disease from China.中国亨廷顿病患者的临床和遗传特征
Neurol Res. 2016 Oct;38(10):916-20. doi: 10.1080/01616412.2016.1214555. Epub 2016 Jul 29.
6
Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.靶向CAG重复RNA可独立于亨廷顿蛋白水平减轻亨廷顿舞蹈病的表型。
J Clin Invest. 2016 Nov 1;126(11):4319-4330. doi: 10.1172/JCI83185. Epub 2016 Oct 10.
7
A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.一项针对 503 例有亨廷顿病症状的印度患者 HTT 基因中 CAG 重复扩增的三引物 PCR 研究。
Mol Diagn Ther. 2018 Jun;22(3):353-359. doi: 10.1007/s40291-018-0327-y.
8
Huntington's Disease: Relationship Between Phenotype and Genotype.亨廷顿舞蹈症:表型与基因型之间的关系
Mol Neurobiol. 2017 Jan;54(1):342-348. doi: 10.1007/s12035-015-9662-8. Epub 2016 Jan 7.
9
The diagnosis and natural history of Huntington disease.亨廷顿舞蹈症的诊断与自然病史。
Handb Clin Neurol. 2017;144:63-67. doi: 10.1016/B978-0-12-801893-4.00005-5.
10
Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.探讨 TBP CAG/CAA 重复与 HTT CAG 重复联合对巴西人群亨廷顿病发病年龄的影响。
J Mol Neurosci. 2022 May;72(5):1116-1124. doi: 10.1007/s12031-021-01938-z. Epub 2022 Mar 11.

引用本文的文献

1
The role of L-DOPA in neurological and neurodegenerative complications: a review.左旋多巴在神经和神经退行性并发症中的作用:综述
Mol Cell Biochem. 2025 Jun 9. doi: 10.1007/s11010-025-05324-w.
2
Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases.探索基于外泌体的神经退行性疾病早期诊断与治疗方法。
Mol Neurobiol. 2025 May 10. doi: 10.1007/s12035-025-05026-w.
3
Time-restricted eating in early-stage Huntington's disease: A 12-week interventional clinical trial protocol.早期亨廷顿舞蹈症的限时饮食:一项为期12周的干预性临床试验方案。

本文引用的文献

1
Body weight is a robust predictor of clinical progression in Huntington disease.体重是亨廷顿病临床进展的有力预测指标。
Ann Neurol. 2017 Sep;82(3):479-483. doi: 10.1002/ana.25007. Epub 2017 Aug 22.
2
HDNetDB: A Molecular Interaction Database for Network-Oriented Investigations into Huntington's Disease.HDNetDB:一个面向网络的亨廷顿病分子相互作用数据库。
Sci Rep. 2017 Jul 12;7(1):5216. doi: 10.1038/s41598-017-05224-0.
3
Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
PLoS One. 2025 Mar 25;20(3):e0319253. doi: 10.1371/journal.pone.0319253. eCollection 2025.
4
Brain Volumetric Analysis Using Artificial Intelligence Software in Premanifest Huntington's Disease Individuals from a Colombian Caribbean Population.使用人工智能软件对来自哥伦比亚加勒比地区人群的临床前期亨廷顿病个体进行脑容量分析。
Biomedicines. 2024 Sep 24;12(10):2166. doi: 10.3390/biomedicines12102166.
5
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease.针对亨廷顿病的衰老和细胞衰老的治疗方法。
CNS Neurosci Ther. 2024 Oct;30(10):e70053. doi: 10.1111/cns.70053.
6
Mitochondrial targeted antioxidants as potential therapy for huntington's disease.线粒体靶向抗氧化剂作为亨廷顿病的潜在治疗方法。
Pharmacol Rep. 2024 Aug;76(4):693-713. doi: 10.1007/s43440-024-00619-z. Epub 2024 Jul 9.
7
Brain-Periphery Interactions in Huntington's Disease: Mediators and Lifestyle Interventions.亨廷顿病的脑-外周相互作用:介导因素和生活方式干预。
Int J Mol Sci. 2024 Apr 25;25(9):4696. doi: 10.3390/ijms25094696.
8
Dietary fasting and time-restricted eating in Huntington's disease: therapeutic potential and underlying mechanisms.饮食禁食和限时进食在亨廷顿病中的作用:治疗潜力和潜在机制。
Transl Neurodegener. 2024 Apr 2;13(1):17. doi: 10.1186/s40035-024-00406-z.
9
Physiological and pathological effects of phase separation in the central nervous system.中枢神经系统中相分离的生理和病理效应。
J Mol Med (Berl). 2024 May;102(5):599-615. doi: 10.1007/s00109-024-02435-7. Epub 2024 Mar 5.
10
Factors Influencing the Total Functional Capacity Score as a Critical Endpoint in Huntington's Disease Research.影响总功能能力评分作为亨廷顿舞蹈症研究关键终点的因素。
Biomedicines. 2023 Dec 17;11(12):3336. doi: 10.3390/biomedicines11123336.
利用定数分析对处于前期亨廷顿病患者的大脑结构磁共振成像变化进行排序和模式分析。
Hum Brain Mapp. 2017 Oct;38(10):5035-5050. doi: 10.1002/hbm.23713. Epub 2017 Jun 28.
4
Cerebellar Gray Matter Alterations in Huntington Disease: A Voxel-Based Morphometry Study.小脑灰质在亨廷顿病中的改变:基于体素的形态测量学研究。
Cerebellum. 2017 Dec;16(5-6):923-928. doi: 10.1007/s12311-017-0865-6.
5
Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.亨廷顿舞蹈症:发病机制与治疗策略
Cold Spring Harb Perspect Med. 2017 Jul 5;7(7):a024240. doi: 10.1101/cshperspect.a024240.
6
Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.感觉运动白质组织的自然变异会影响亨廷顿舞蹈病的表现。
Hum Brain Mapp. 2016 Dec;37(12):4615-4628. doi: 10.1002/hbm.23332. Epub 2016 Aug 1.
7
Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington's Disease.视空间处理缺陷与临床前及早期亨廷顿舞蹈病患者后脑区域相关
J Int Neuropsychol Soc. 2016 Jul;22(6):595-608. doi: 10.1017/S1355617716000321. Epub 2016 May 23.
8
Huntington disease.亨廷顿舞蹈病。
Nat Rev Dis Primers. 2015 Apr 23;1:15005. doi: 10.1038/nrdp.2015.5.
9
The Biology of Huntingtin.亨廷顿蛋白的生物学。
Neuron. 2016 Mar 2;89(5):910-26. doi: 10.1016/j.neuron.2016.02.003.
10
Current status of PET imaging in Huntington's disease.正电子发射断层显像(PET)在亨廷顿舞蹈症中的应用现状
Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1171-82. doi: 10.1007/s00259-016-3324-6. Epub 2016 Feb 22.